De Jong EMGJ - Search Results

1

Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review.

Van Enst WA, Weng YC, Wanten SAC, Seyger MMB, Baerveldt EM, Arents BWM, De Jong EMGJ, Van den Reek JMPA. Van Enst WA, et al. Among authors: de jong emgj. Acta Derm Venereol. 2024 May 15;104:adv23901. doi: 10.2340/actadv.v104.23901. Acta Derm Venereol. 2024. PMID: 38751176 Free PMC article.

2

A therapeutic approach to erythrodermic psoriasis: report of a case and a discussion of therapeutic options.

van der Vleuten CJ, Gerritsen MJ, Steijlen PM, de Jong EM, van de Kerkhof PC. van der Vleuten CJ, et al. Acta Derm Venereol. 1996 Jan;76(1):65-7. doi: 10.2340/00015555766567. Acta Derm Venereol. 1996. PMID: 8721498 Free article.

3

Altered distribution of heparan sulfate proteoglycans in psoriasis.

Seyger MM, van den Born J, Schalkwijk J, van de Kerkhof PC, de Jong EM. Seyger MM, et al. Acta Derm Venereol. 1997 Mar;77(2):105-9. doi: 10.2340/0001555577105109. Acta Derm Venereol. 1997. PMID: 9111818 Free article. Clinical Trial.

4

Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.

Seyger MM, van Pelt JP, van den Born J, Latijnhouwers MA, de Jong EM. Seyger MM, et al. Arch Dermatol Res. 1997 May;289(6):331-6. doi: 10.1007/s004030050200. Arch Dermatol Res. 1997. PMID: 9209678 Free article.

5

Reliability of two methods to assess morphea: skin scoring and the use of a durometer.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):793-6. doi: 10.1016/s0190-9622(97)70121-x. J Am Acad Dermatol. 1997. PMID: 9366834 Free article. Clinical Trial. No abstract available.

6

Low-dose methotrexate in the treatment of widespread morphea.

Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Seyger MM, et al. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):220-5. doi: 10.1016/s0190-9622(98)70079-9. J Am Acad Dermatol. 1998. PMID: 9704833 Clinical Trial.

7

The efficacy of a new topical treatment for psoriasis: Mirak.

Seyger MM, van de Kerkhof PC, van Vlijmen-Willems IM, de Bakker ES, Zwiers F, de Jong EM. Seyger MM, et al. J Eur Acad Dermatol Venereol. 1998 Jul;11(1):13-8. J Eur Acad Dermatol Venereol. 1998. PMID: 9731960 Clinical Trial.

8

Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus.

Seyger MM, van Bruggen MC, Hardeman HK, van den Hoogen FH, Berden JH, van den Born J, De Jong EM. Seyger MM, et al. Acta Derm Venereol. 1998 Sep;78(5):326-30. doi: 10.1080/000155598442971. Acta Derm Venereol. 1998. PMID: 9779246 Free article.

9

Localized and systemic scleroderma show different histological responses to methotrexate therapy.

Seyger MM, van den Hoogen FH, van Vlijmen-Willems IM, van de Kerkhof PC, de Jong EM. Seyger MM, et al. J Pathol. 2001 Apr;193(4):511-6. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH779>3.0.CO;2-8. J Pathol. 2001. PMID: 11276011

10

Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.

Bovenschen HJ, Gerritsen WJ, van Rens DW, Seyger MM, de Jong EM, van de Kerkhof PC. Bovenschen HJ, et al. Arch Dermatol Res. 2007 Feb;298(9):457-63. doi: 10.1007/s00403-006-0716-7. Epub 2006 Nov 30. Arch Dermatol Res. 2007. PMID: 17136563 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters